Spero Therapeutics to Present at March Investor Conferences

CAMBRIDGE, Mass. , March 01, 2018 (GLOBE NEWSWIRE) — Spero Therapeutics , Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial infections, announced today that Ankit

READ FULL TEXT

Leave a Reply

Your email address will not be published.